Метаболические и антигипертензивные эффекты моксонидина и комбинации моксонидина с ирбесартаном у пациентов с сахарным диабетом 2-го типа и умеренной гипертензией: последовательное рандомизированное двойное слепое клиническое исследование

Giuseppe Derosa
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Arrigo F.g. Cicero
G. Descovich" Atherosclerosis Study Center, "D. Campanacci" Clinical Medicine and Applied Biotecknology Department, University of Bologna, Italy
Россия

Angela D'angelo
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Elena Fogari
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Sibilla Salvadeo
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Alessia Gravina
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Ilaria Ferrari
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Raffaella Fassi
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия

Roberto Fogari
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico, S. Matteo, Pavia, Italy
Россия